Breast Cancer Research and Treatment

, Volume 160, Issue 3, pp 531–537 | Cite as

Investigation of breast cancer sub-populations in black and white women in South Africa

  • Caroline Dickens
  • Ruth M. Pfeiffer
  • William F. Anderson
  • Raquel Duarte
  • Patricia Kellett
  • Joachim Schüz
  • Danuta Kielkowski
  • Valerie A. McCormack
Epidemiology
  • 370 Downloads

Abstract

Purpose

Bimodal age distributions at diagnosis have been widely observed among US and European female breast cancer populations. To determine whether bimodal breast cancer distributions are also present in a sub-Saharan African population, we investigated female breast cancer in South Africa.

Methods

Using the South African National Cancer Registry data, we examined age-at-diagnosis frequency distributions (density plots) for breast cancer overall and by their receptor (oestrogen, progesterone and HER2) determinants among black and white women diagnosed during 2009–2011 in the public healthcare sector. For comparison, we also analysed corresponding 2010–2011 US SEER data. We investigated density plots using flexible mixture models, allowing early/late-onset membership to depend on receptor status.

Results

We included 8857 women from South Africa, 7176 (81 %) with known oestrogen receptor status, and 95064 US women. Bimodality was present in all races, with an early-onset mode between ages 40–50 years and a late-onset mode among ages 60–70 years. The early-onset mode was younger in South African black women (age 38), compared to other groups (45–54 years).

Conclusions

Consistent patterns of bimodality and of its receptor determinants were present across breast cancer patient populations in South Africa and the US. Although the clinical spectrum of breast cancer is well acknowledged as heterogeneous, universal early- and late-onset age distributions at diagnosis suggest that breast cancer etiology consists of a mixture two main types.

Keywords

Breast cancer Receptors Age distributions South Africa 

Abbreviations

AIC

Akaike information criterion

CI

Confidence interval

ER

Oestrogen receptor

FISH

Fluorescence in situ hybridization

HER2E

Human-epidermal growth factor-2 enriched (ERPRHER2+)

IHC

Immunohistochemistry

PR

Progesterone receptor

SA

South Africa

SEER

Surveillance, Epidemiology, and End Results

US

United States

Notes

Funding

The work reported in this paper was undertaken during the tenure of a Postdoctoral Fellowship to Dr Dickens from the International Agency for Research on Cancer, partially supported by the European Commission FP7 Marie Curie Actions – People – Co-funding of regional, national and international programmes (COFUND).

Compliance with ethical standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Supplementary material

10549_2016_4019_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 16 kb)

References

  1. 1.
    Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME (2014) How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst 106(8):dju165CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ et al (2012) The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 486(7403):346–352PubMedPubMedCentralGoogle Scholar
  3. 3.
    Armitage P, Doll R (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8(1):1–12CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 98(14):948–951CrossRefPubMedGoogle Scholar
  5. 5.
    Anderson WF, Rosenberg PS, Petito L, Katki HA, Ejlertsen B, Ewertz M et al (2013) Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark. Int J Cancer 133(9):2201–2206CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Matsuno RK, Anderson WF, Yamamoto S, Tsukuma H, Pfeiffer RM, Kobayashi K et al (2007) Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomark Prev 16(7):1437–1442CrossRefGoogle Scholar
  7. 7.
    Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev 15(10):1899–1905CrossRefGoogle Scholar
  8. 8.
    Escarela G, Perez-Ruiz LC, Nunez-Antonio G (2014) Temporal trend, clinicopathologic and sociodemographic characterization of age at diagnosis of breast cancer among US women diagnosed from 1990 to 2009. Springerplus 3:626CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96(3):218–228CrossRefPubMedGoogle Scholar
  10. 10.
    Dickens C, Duarte R, Zietsman A, Cubasch H, Kellett P, Schuz J et al (2014) Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data. Cancer Epidemiol Biomark Prev 23(11):2311–2321CrossRefGoogle Scholar
  11. 11.
    National Cancer Registry (2012) Cancer in South Africa 2006 Full Report. National Health Laboratory ServiceGoogle Scholar
  12. 12.
    Mayosi BM, Lawn JE, van Niekerk A, Bradshaw D, Abdool Karim SS, Coovadia HM (2012) Health in South Africa: changes and challenges since 2009. Lancet 380(9858):2029–2043CrossRefPubMedGoogle Scholar
  13. 13.
    Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence—SEER 18 Regs Research Data+ Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973-2011 varying)—Linked To County Attributes—Total U.S., 1969–2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2014), based on the November 2013 submission. www. seer. cancer. gov 2014
  14. 14.
    Anderson WF, Katki HA, Rosenberg PS (2011) Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103(18):1397–1402CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502CrossRefPubMedGoogle Scholar
  16. 16.
    Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10(16):5367–5374CrossRefPubMedGoogle Scholar
  17. 17.
    Pfeiffer RM, Carroll RJ, Wheeler W, Whitby D, Mbulaiteye S (2008) Combining assays for estimating prevalence of human herpesvirus 8 infection using multivariate mixture models. Biostatistics 9(1):137–151CrossRefPubMedGoogle Scholar
  18. 18.
    Muguti GI (1993) Experience with breast cancer in Zimbabwe. J R Coll Surg Edinb 38(2):75–78PubMedGoogle Scholar
  19. 19.
    Sighoko D, Kamate B, Traore C, Malle B, Coulibaly B, Karidiatou A et al (2013) Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life. Breast 22(5):828–835CrossRefPubMedGoogle Scholar
  20. 20.
    Dickens C, Joffe M, Jacobson J, Venter F, Schuz J, Cubasch H et al (2014) Stage at breast cancer diagnosis and distance from diagnostic hospital in a peri-urban setting: a South African public hospital case series of over 1000 women. Int J Cancer 135(9):2173–2182CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, Williams S et al (2010) Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci USA 107(2):786–791CrossRefPubMedGoogle Scholar
  22. 22.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed on 20 Dec 2013)
  23. 23.
    Statistics SA (2010) Estimation of fertility from the 2007 community survey of South Africa. no. 03-00-04 (2010) ed. Pretoria South Africa : Statistics South AfricaGoogle Scholar
  24. 24.
    Statistics South Africa 2011 National Census. http://interactive.statssa.gov.za/superweb/login.do2013 [cited 4 Feb 2013]
  25. 25.
    Kobayashi H, Ohno S, Sasaki Y, Matsuura M (2013) Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep 30(3):1019–1029PubMedGoogle Scholar
  26. 26.
    Molyneux G, Smalley MJ (2011) The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling. J Mammary Gland Biol Neoplasia 16(1):51–55CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Section of Environment and RadiationInternational Agency for Research on CancerLyonFrance
  2. 2.Department of Internal Medicine, Faculty of Health SciencesUniversity of the WitwatersrandJohannesburgSouth Africa
  3. 3.Division of Cancer Epidemiology and GeneticsNational Cancer Institute, Biostatistics BranchBethesdaUSA
  4. 4.National Cancer Registry of South AfricaNational Health and Laboratory ServicesJohannesburgSouth Africa

Personalised recommendations